- Home
- HEPS vs KURA Comparison
HEPS vs KURA Comparison
Compare HEPS & KURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$2.64
HOLD
Current Price
$9.60
Company Overview
Basic Information| Metric | HEPS | KURA |
|---|---|---|
| Founded | 2000 | 2014 |
| Country | Turkey | United States |
| Employees | N/A | N/A |
| Industry | Catalog/Specialty Distribution | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 870.4M | 1.0B |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | HEPS | KURA |
|---|---|---|
| Price | $2.64 | $9.60 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 11 |
| Target Price | $3.07 | ★ $25.00 |
| AVG Volume (30 Days) | 464.2K | ★ 1.7M |
| Earning Date | 11-05-2025 | 02-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,504,533,586.00 | $104,029,000.00 |
| Revenue This Year | $41.69 | $138.16 |
| Revenue Next Year | $29.78 | $66.98 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 56.77 | N/A |
| 52 Week Low | $2.15 | $5.41 |
| 52 Week High | $3.85 | $12.49 |
Technical Indicators
Market Signals| Indicator | HEPS | KURA |
|---|---|---|
| Relative Strength Index (RSI) | 57.51 | 39.27 |
| Support Level | $2.46 | $10.11 |
| Resistance Level | $2.58 | $10.51 |
| Average True Range (ATR) | 0.19 | 0.52 |
| MACD | 0.01 | -0.09 |
| Stochastic Oscillator | 33.33 | 9.31 |
Price Performance
Historical Comparison HEPS
KURA
About HEPS D-Market Electronic Services & Trading
D-MARKET Electronic Services & Trading offers an e-commerce platform in Turkey and the surrounding region. The company is comprised of one reportable segment, namely e-commerce operations. The Group derives revenue from the sales of goods, marketplace revenues and other revenues.
About KURA Kura Oncology Inc.
Kura Oncology Inc is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The company's pipeline consists of small molecule drug candidates targeting cancer signaling pathways.